Richard Close
Stock Analyst at Canaccord Genuity
(1.96)
# 3,655
Out of 5,182 analysts
155
Total ratings
37.7%
Success rate
-9.8%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AHCO AdaptHealth | Maintains: Buy | $14 → $16 | $11.41 | +40.29% | 9 | May 6, 2026 | |
| PHR Phreesia | Maintains: Buy | $33 → $22 | $9.53 | +130.85% | 13 | Mar 31, 2026 | |
| DCGO DocGo | Maintains: Hold | $1.5 → $1 | $0.62 | +60.77% | 9 | Mar 25, 2026 | |
| CLOV Clover Health Investments | Maintains: Buy | $3.7 → $3.2 | $2.68 | +19.40% | 7 | Mar 20, 2026 | |
| HCAT Health Catalyst | Maintains: Buy | $5 → $2 | $1.57 | +27.39% | 10 | Mar 13, 2026 | |
| PGNY Progyny | Maintains: Hold | $26 → $19 | $18.70 | +1.60% | 10 | Mar 11, 2026 | |
| TALK Talkspace | Downgrades: Hold | n/a | $5.19 | - | 3 | Mar 9, 2026 | |
| OMDA Omada Health | Maintains: Buy | $28 → $22 | $15.86 | +38.71% | 3 | Mar 6, 2026 | |
| PRVA Privia Health Group | Maintains: Buy | $34 → $35 | $23.97 | +46.02% | 10 | Feb 27, 2026 | |
| TDOC Teladoc Health | Maintains: Buy | $12 → $10 | $6.80 | +47.06% | 17 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $7.36 | +35.87% | 2 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $30 | $19.90 | +50.75% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $53 | $54.84 | -3.36% | 4 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $34 | $25.69 | +32.35% | 14 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 | $23.15 | +20.95% | 9 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $9 | $3.83 | +134.99% | 13 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $141.38 | -14.42% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $20.45 | +17.36% | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $63.95 | +48.55% | 9 | Apr 22, 2021 |
AdaptHealth
May 6, 2026
Maintains: Buy
Price Target: $14 → $16
Current: $11.41
Upside: +40.29%
Phreesia
Mar 31, 2026
Maintains: Buy
Price Target: $33 → $22
Current: $9.53
Upside: +130.85%
DocGo
Mar 25, 2026
Maintains: Hold
Price Target: $1.5 → $1
Current: $0.62
Upside: +60.77%
Clover Health Investments
Mar 20, 2026
Maintains: Buy
Price Target: $3.7 → $3.2
Current: $2.68
Upside: +19.40%
Health Catalyst
Mar 13, 2026
Maintains: Buy
Price Target: $5 → $2
Current: $1.57
Upside: +27.39%
Progyny
Mar 11, 2026
Maintains: Hold
Price Target: $26 → $19
Current: $18.70
Upside: +1.60%
Talkspace
Mar 9, 2026
Downgrades: Hold
Price Target: n/a
Current: $5.19
Upside: -
Omada Health
Mar 6, 2026
Maintains: Buy
Price Target: $28 → $22
Current: $15.86
Upside: +38.71%
Privia Health Group
Feb 27, 2026
Maintains: Buy
Price Target: $34 → $35
Current: $23.97
Upside: +46.02%
Teladoc Health
Feb 26, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $6.80
Upside: +47.06%
Feb 26, 2026
Maintains: Buy
Price Target: $9 → $10
Current: $7.36
Upside: +35.87%
Feb 18, 2026
Maintains: Buy
Price Target: $54 → $30
Current: $19.90
Upside: +50.75%
Feb 11, 2026
Maintains: Buy
Price Target: $65 → $53
Current: $54.84
Upside: -3.36%
Feb 9, 2026
Upgrades: Buy
Price Target: $48 → $34
Current: $25.69
Upside: +32.35%
Dec 17, 2025
Maintains: Hold
Price Target: $28
Current: $23.15
Upside: +20.95%
Nov 14, 2025
Maintains: Buy
Price Target: $16 → $9
Current: $3.83
Upside: +134.99%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $141.38
Upside: -14.42%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $20.45
Upside: +17.36%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $63.95
Upside: +48.55%